Ring Mountain Capital’s Profound Medical PROF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.4M Buy
511,917
+812
+0.2% +$5.46K 1.43% 17
2026
Q1
$3.31M Buy
511,105
+57,025
+13% +$394K 1.81% 14
2025
Q4
$3.73M Buy
454,080
+59,216
+15% +$381K 1.91% 13
2025
Q3
$1.93M Buy
394,864
+36,444
+10% +$186K 1.07% 20
2025
Q2
$2.02M Buy
358,420
+51,463
+17% +$272K 1.23% 18
2025
Q1
$1.79M Buy
306,957
+29,098
+10% +$201K 1.34% 19
2024
Q4
$2.09M Buy
+277,859
New +$2.13M 1.4% 17

Other funds holding PROF

Ring Mountain Capital's PROF Position: Q2 2026 in Review

Ring Mountain Capital increased its Profound Medical (PROF) stake by 0.16% in Q2 2026, buying an estimated $5.46K and bringing the position to 511,917 shares worth $3.4M. The position accounts for 1.43% of the portfolio, ranked #17.

Ring Mountain Capital first reported a position in PROF in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.73M in Q4 2025. 56 funds tracked by Wall St. Rank hold PROF as of Q2 2026.

  • Ring Mountain Capital held 511,917 shares of Profound Medical worth $3.4M as of Q2 2026.
  • Ring Mountain Capital bought 812 Profound Medical shares in Q2 2026, an estimated $5.46K.
  • Profound Medical made up 1.43% of Ring Mountain Capital's portfolio in Q2 2026, its #17 holding.
  • Ring Mountain Capital first reported a position in Profound Medical in Q4 2024 and has held it in 7 quarters since.
  • Ring Mountain Capital's Profound Medical position peaked at $3.73M in Q4 2025.
  • 56 funds tracked by Wall St. Rank held Profound Medical as of Q2 2026.

Based on Ring Mountain Capital's 13F filing for Q2 2026, filed 11 Aug 2026.